Timothy R. Cote - 03 May 2023 Form 3 Insider Report for SOLIGENIX, INC. (SNGX)

Reporting relationship: Director
Issuer ticker: SNGX
Reported as of: 03 May 2023
Net transaction value: $0
SEC form: 3
Accepted by SEC: 05 May 2023, 18:25:54 UTC
Source filing: View source filing
Reporting owner signature: /s/ Timothy R. Cote

Key filing fact

Timothy R. Cote filed Form 3 for SOLIGENIX, INC. (SNGX) on 05 May 2023.

Key facts

This page summarizes Timothy R. Cote's Form 3 filing for SOLIGENIX, INC. (SNGX).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 05 May 2023, 18:25.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SNGX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 25,317
Date: 03 May 2023
Ownership: Silk Road Therapeutics, Inc.
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported units for purposes of Section 16 or for any other purpose.